Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-21-016064
Filing Date
2021-11-16
Accepted
2021-11-16 09:19:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A tmb-20211116xdefa14a.htm DEFA14A 37759
  Complete submission text file 0001558370-21-016064.txt   38915
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-35023 | Film No.: 211414298
SIC: 2834 Pharmaceutical Preparations